HomeENSC • NASDAQ
add
Ensysce Biosciences Inc
Previous close
$0.59
Day range
$0.42 - $0.56
Year range
$0.14 - $2.06
Market cap
6.44M USD
Avg Volume
56.13M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 3.42M | 685.26% |
Operating expense | 1.08M | -11.75% |
Net income | 661.77K | 124.61% |
Net profit margin | 19.36 | 103.13% |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.15M | 183.64% |
Total assets | 9.38M | 191.57% |
Total liabilities | 2.80M | 36.10% |
Total equity | 6.58M | — |
Shares outstanding | 19.57M | — |
Price to book | 1.18 | — |
Return on assets | 26.47% | — |
Return on capital | 36.22% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 661.77K | 124.61% |
Cash from operations | -1.02M | 54.91% |
Cash from investing | — | — |
Cash from financing | 4.13M | 4,131.70% |
Net change in cash | 3.11M | 231.51% |
Free cash flow | -1.54M | -18.89% |
About
Founded
2003
Headquarters
Website
Employees
7
